EUR 39.2
(1.82%)
Year | Eps | Eps Growth |
---|---|---|
2023 | 1.16 EUR | -53.41% |
2022 | 2.49 EUR | -35.99% |
2021 | 3.89 EUR | 144.65% |
2020 | 1.59 EUR | 11.19% |
2019 | 1.43 EUR | 1.42% |
2018 | 1.41 EUR | -9.62% |
2017 | 1.56 EUR | 1.3% |
2016 | 1.54 EUR | 541.67% |
2015 | 0.24 EUR | 21918.18% |
2014 | -0.00 EUR | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | 0.32 EUR | -60.49% |
2024 Q1 | 0.81 EUR | 1720.0% |
2023 Q3 | 0.46 EUR | 370.59% |
2023 Q4 | -0.05 EUR | -110.87% |
2023 FY | - EUR | -53.41% |
2023 Q1 | 0.92 EUR | 67.27% |
2023 Q2 | -0.17 EUR | -118.48% |
2022 Q1 | 0.69 EUR | -47.73% |
2022 FY | - EUR | -35.99% |
2022 Q2 | 0.27 EUR | -60.87% |
2022 Q4 | 0.55 EUR | -43.88% |
2022 Q3 | 0.98 EUR | 262.96% |
2021 Q4 | 1.32 EUR | 14.78% |
2021 FY | - EUR | 144.65% |
2021 Q2 | 0.74 EUR | 10.45% |
2021 Q3 | 1.15 EUR | 55.41% |
2021 Q1 | 0.67 EUR | 48.89% |
2020 Q4 | 0.45 EUR | 7.14% |
2020 FY | - EUR | 11.19% |
2020 Q3 | 0.42 EUR | 90.91% |
2020 Q2 | 0.22 EUR | -56.0% |
2020 Q1 | 0.50 EUR | 47.06% |
2019 Q2 | 0.38 EUR | 5.56% |
2019 FY | - EUR | 1.42% |
2019 Q1 | 0.36 EUR | 28.57% |
2019 Q4 | 0.34 EUR | -2.86% |
2019 Q3 | 0.35 EUR | -7.89% |
2018 Q4 | 0.28 EUR | -31.71% |
2018 FY | - EUR | -9.62% |
2018 Q2 | 0.31 EUR | -24.39% |
2018 Q1 | 0.41 EUR | 51.85% |
2018 Q3 | 0.41 EUR | 32.26% |
2017 Q2 | 0.39 EUR | -4.88% |
2017 Q3 | 0.43 EUR | 10.26% |
2017 Q1 | 0.41 EUR | 5.13% |
2017 FY | - EUR | 1.3% |
2017 Q4 | 0.27 EUR | -37.21% |
2016 FY | - EUR | 541.67% |
2016 Q4 | 0.39 EUR | 0.0% |
2015 FY | - EUR | 21918.18% |
2014 FY | - EUR | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
MPH Health Care AG | 6.90 EUR | 83.188% |
Apontis Pharma AG | -1.33 EUR | 187.218% |
Evotec SE | -0.47 EUR | 346.809% |
MERCK Kommanditgesellschaft auf Aktien | 6.50 EUR | 82.154% |
PharmaSGP Holding SE | 1.37 EUR | 15.328% |
SynBiotic SE | -2.24 EUR | 151.786% |